Rhodes Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsRhodes Pharmaceuticals

Rhodes Pharmaceuticals

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Acetaminophen codeine	Acetaminophen, Codeine	1988-02-10	2025-2039	Pain , Fever , Cough , Postoperative pain , Obstructive lung diseases , Headache , Fatigue , Apnea , Rheumatoid arthritis , Inflammation , Osteoarthritis , Rheumatic fever , Gout , Juvenile arthritis , Menorrhagia , Ankylosing spondylitis , Bursitis , Dysmenorrhea , Premenstrual syndrome , Sinusitis , Asthma , Common cold , Allergic rhinitis perennial , Urticaria , Angioedema
Amphetamine	Amphetamine	2021-09-07	2024-2038	Narcolepsy , Attention deficit disorder with hyperactivity
Aptensio	Methylphenidate	2015-04-17	2024-2038	Narcolepsy , Attention deficit disorder with hyperactivity , Depressive disorder
Brompheniramine maleate, pseudoephedrine dextromethorphan	Brompheniramine, Dextromethorphan, Pseudoephedrine	2020-11-05	2023-2040	Atrial fibrillation, Atrial flutter, Cardiac arrhythmias, Cough, Neurobehavioral manifestations, Sinusitis, Asthma, Common cold, Allergic rhinitis perennial, Urticaria, Vasomotor rhinitis, Whooping cough, Bronchitis, Pharyngitis, Laryngitis, Postoperative complications, Pain, Vomiting, Nausea, Anaphylaxis, Allergic conjunctivitis, Motion sickness, Tobacco use disorder, Attention deficit disorder with hyperactivity, Depressive disorder
Buprenorphine	Buprenorphine	2017-03-27	2024-2038	Septic shock, Pain, Opioid-related disorders, Heroin dependence, Respiration disorders
Buprenorphine naloxone	Buprenorphine, Naloxone	2020-03-30	2024-2038	Septic shock, Pain, Opioid-related disorders, Heroin dependence, Respiration disorders
Dexmethylphenidate	Dexmethylphenidate	2017-11-20	2032-2037	Attention deficit disorder with hyperactivity
Dextroamp saccharate, amp aspartate, dextroamp amp	Amphetamine, Amphetamine aspartate, Dextroamphetamine, Dextroamphetamine saccharate	2019-05-17	2024-2038	Narcolepsy, Attention deficit disorder with hyperactivity
Dilaudid	Hydromorphone	1992-12-07	2032-2034	Postoperative pain, Cough
Fenofibrate	Fenofibrate	2002-04-09	2024-2033	Hypercholesterolemia, Coronary artery disease, Dyslipidemias, Hypertriglyceridemia, Hyperlipoproteinemias
Hydrocodone acetaminophen	Acetaminophen, Hydrocodone	2016-04-12	2025-2039	Pain, Fever, Cough, Postoperative pain, Obstructive lung diseases, Headache, Fatigue, Apnea, Rheumatoid arthritis, Inflammation, Osteoarthritis, Rheumatic fever, Gout, Juvenile arthritis, Menorrhagia, Ankylosing spondylitis, Bursitis, Dysmenorrhea, Premenstrual syndrome, Sinusitis, Asthma, Common cold, Allergic rhinitis perennial, Urticaria, Angioedema

1

2

>

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Methylphenidate

attention deficit disorder with hyperactivity

,

Lisdexamfetamine dimesylate

attention deficit disorder with hyperactivity

Lisdexamfetamine

attention deficit disorder with hyperactivity

attention deficit disorder with hyperactivity

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use